CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...
Biotech investor MPM Capital has put together a $400 million new fund with help from Big Pharma, scouting for innovative startups with an eye on build-to-buy deals ...
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) announced that the company has concluded an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results